Charlie McDermott
North America, California, United States
Description
Charlie McDermott, Chairman, President & Chief Executive Officer at Primmune Therapeutics.
Investor Profile
Charlie McDermott has made 2 investments, with 0 in the past 12 months and 0% as lead.
Stage Focus
- Series A (50%)
- Seed (50%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
